Clinical Trial Update: Opioid-induced Hyperalgesia After Remifentanil Infusion [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating opioid-induced hyperalgesia after remifentanil infusion. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperalgesia

Drugs mentioned

• Remifentanil (remifentanil)

Snippet

Sponsor: Oslo University Hospital | Conditions: Hyperalgesia | Phase 4 | Status: COMPLETED